Free tool

Diagnostics stocks

We cover 15 companies grouped under the Diagnostics theme. The median market value in the group is $4.72B. Across the group, the median move over the past trading day is +2.74%. Price change over the past year runs from −20.6% to +164.0% across the middle 80 percent of the group, with a median of +49.0%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

15 of 150 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y return
NTRANatera, Inc.$336.71+30.49%+47.14%+107.24%
LHLabcorp Holdings Inc.$337.68+12.12%+34.52%+23.25%
DGXQuest Diagnostics Incorporated$244.51+5.46%+41.95%+38.70%
GHGuardant Health, Inc.$164.92+13.37%+62.10%+166.52%
TEMTempus AI, Inc.$68.73+60.17%+10.21%−9.45%
QGENQiagen N.V.$43.65+6.26%−3.41%−10.74%
CAICaris Life Sciences, Inc.$28.01+79.21%+3.82%−27.21%
BLLNBillionToOne, Inc.$100.08−21.80%+12.08%−8.14%
ADPTAdaptive Biotechnologies Corporation$26.25+16.46%+64.99%+107.18%
GRALGRAIL, Inc.$82.54+23.62%−7.12%+150.69%
VCYTVeracyte, Inc. Common Stock$44.04−20.81%+3.89%+49.04%
CDNACareDx, Inc.$50.80+39.71%+165.41%+298.43%
WGSGeneDx Holdings Corp.$87.41+44.38%−33.93%−28.28%
NEOGNeogen Corporation$11.64+24.63%+66.29%+107.86%
NEONeoGenomics, Inc.$16.79+27.78%+42.77%+160.31%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse